Robins Harlan S: insider trades.
Robins Harlan S reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($19.3M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- ROBINS HARLAN S
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Officer · Chief Scientific Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-21 | Adaptive Biotechnologies Corp | S | 213,702 | $22.12 | 812,058 | Form 4 |
| 2026-07-21 | Adaptive Biotechnologies Corp | S | 278,698 | $21.72 | 1,025,760 | Form 4 |
| 2026-07-21 | Adaptive Biotechnologies Corp | M | 284,800 | $6.55 | 1,304,458 | Form 4 |
| 2026-07-02 | Adaptive Biotechnologies Corp | S | 239,351 | $21.74 | 1,166,547 | Form 4 |
| 2026-07-02 | Adaptive Biotechnologies Corp | S | 146,889 | $22.45 | 1,019,658 | Form 4 |
Questions
What stock did Robins Harlan S buy or sell?
Robins Harlan S reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($19.3M), across 1 company.
Is Robins Harlan S the same person as other filers with this name?
This page covers SEC CIK 1780851 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/robins-harlan-s-1780851.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.